New therapeutics for the prevention and reduction of scarring.
about
Anti-fibrotic actions of interleukin-10 against hypertrophic scarring by activation of PI3K/AKT and STAT3 signaling pathways in scar-forming fibroblastsGene delivery of a mutant TGFβ3 reduces markers of scar tissue formation after cutaneous woundingTransforming growth factor-(beta)s and mammary gland involution; functional roles and implications for cancer progression.New molecular medicine-based scar management strategiesExtracellular matrix molecules: potential targets in pharmacotherapy.Characteristics of scar margin dynamic with time based on multiphoton microscopy.Quantification of scar margin in keloid different from atrophic scar by multiphoton microscopic imaging.Therapeutic improvement of scarring: mechanisms of scarless and scar-forming healing and approaches to the discovery of new treatmentsUp-to-date approach to manage keloids and hypertrophic scars: a useful guide.Scarless skin wound healing in FOXN1 deficient (nude) mice is associated with distinctive matrix metalloproteinase expression.Acute and impaired wound healing: pathophysiology and current methods for drug delivery, part 2: role of growth factors in normal and pathological wound healing: therapeutic potential and methods of delivery.Co-transfection of decorin and interleukin-10 modulates pro-fibrotic extracellular matrix gene expression in human tenocyte cultureIL10 inhibits starvation-induced autophagy in hypertrophic scar fibroblasts via cross talk between the IL10-IL10R-STAT3 and IL10-AKT-mTOR pathways.Intracellular signaling mechanisms associated with CD47 modified surfaces.TGF-β3 modulates the inflammatory environment and reduces scar formation following vocal fold mucosal injury in rats.Avotermin for the improvement of scar appearance: a new pharmaceutical in a new therapeutic area.Recent advances in dermal wound healing: biomedical device approaches.Mechanotransduction and fibrosis.Impact of surgical innovation on tissue repair in the surgical patient.Therapies with emerging evidence of efficacy: avotermin for the improvement of scarring.The impact of varying post-operative dressing size on recovery from laparoscopic cholecystectomy.Human Endomyocardial Biopsy Specimen-Derived Stromal Cells Modulate Angiotensin II-Induced Cardiac Remodeling.[Postoperative care and options for scar treatment in eyelid surgery].Embryonic Skin Development and Repair.A synthetic gene increases TGFβ3 accumulation by 75-fold in tobacco chloroplasts enabling rapid purification and folding into a biologically active molecule.Topical application of a film-forming emulgel dressing that controls the release of stratifin and acetylsalicylic acid and improves/prevents hypertrophic scarring.
P2860
Q28539207-3A0AA23B-D2E4-4B68-8110-A3C9E066DD0AQ30497588-325B863B-DA46-40D5-8414-9D459B0668E2Q33553226-3EFB7029-5A77-4786-8934-41AE28881620Q33560989-C65D4810-9F31-4122-BED8-08F0357E6959Q33694487-0CAFA11E-BF43-4F58-960F-55BB3029CA1BQ33723069-8BC9DE6E-2FE3-4210-BBA0-A274EA8DA6A9Q33881965-DCF0CB22-CCC9-4911-99CD-878B9F227C73Q34089270-3CF41B5F-045F-40ED-810E-F2F1820F292DQ34294681-FE8058EA-B7E9-4F14-A6B3-D118422F7C0BQ35042802-1B2FC2EE-7C3C-43C1-AF2A-8FF565D277FCQ36186814-6C041FFA-6C57-45B6-87DE-D7CF90D7187EQ36565065-AEEA6802-52ED-4B1B-A821-8F2BAA258013Q36774975-2457CB65-848C-4D0E-A002-25D2F02F5A92Q37244592-584E19FF-B892-46BB-BFDA-B3A08717823BQ37438508-78010BAC-AD34-4F29-B8E0-38CCBD0ACE1FQ37551928-A8348E26-3166-4ED2-A709-BBB94105DB64Q37658830-C5A20FB0-C8B1-49B5-A52C-91450A4FCD82Q38202790-D6386674-F2CE-42B5-BA93-FD41924AC63DQ38334682-808A3473-3759-45A6-A7CF-D044E686EECBQ42460729-5DF327B8-2C2C-4874-BD94-94A0CFB25E60Q46146987-83374A66-4194-4C7F-A03F-6F8EC77871BCQ46510689-EC4B81C9-674A-4613-B8EA-69A9E21FB0F2Q49502778-B4EC231F-1B5B-4421-AD54-A5D8DD670207Q50116250-D80CC5AE-1FE2-4D3B-AA1B-ED981512E39DQ50278167-3AA528B0-28D8-43B8-A91E-00924E7D838DQ53135770-5F31734E-5BA3-47B6-9BDF-6B579A685831
P2860
New therapeutics for the prevention and reduction of scarring.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
New therapeutics for the prevention and reduction of scarring.
@en
New therapeutics for the prevention and reduction of scarring.
@nl
type
label
New therapeutics for the prevention and reduction of scarring.
@en
New therapeutics for the prevention and reduction of scarring.
@nl
prefLabel
New therapeutics for the prevention and reduction of scarring.
@en
New therapeutics for the prevention and reduction of scarring.
@nl
P2093
P1433
P1476
New therapeutics for the prevention and reduction of scarring.
@en
P2093
Mark W J Ferguson
Nick Goldspink
Nick L Occleston
Sharon O'Kane
P304
P356
10.1016/J.DRUDIS.2008.08.009
P577
2008-10-15T00:00:00Z